Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk. [PDF]
Soga R +4 more
europepmc +1 more source
Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]
Sklepinski S +15 more
europepmc +1 more source
Identifying high-risk combinations of metformin during COVID-19. [PDF]
Dimnjaković J +5 more
europepmc +1 more source
Insulin autoimmune hypoglycemia unmasking monoclonal gammopathy in type 2 diabetes. [PDF]
Prasad S +5 more
europepmc +1 more source
Genotype-derived interpretive categories of drug response in 908 pharmacogenomic reports from Chinese patients with type 2 diabetes: A retrospective single-centre study. [PDF]
Liu Y, Yu CX, Lu L.
europepmc +1 more source
The Development of Anti-Tumor Activity of Sulfonylurea Compounds
openaire +1 more source
The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. [PDF]
Zou C +5 more
europepmc +1 more source
[Case of hypersensitivity to sulfonylurea compounds].
openaire +1 more source
Glycemic Control and Utilization Risk With the Conversion of Glimepiride to Glipizide in Adults 64 Years and Older at an Integrated Health Care System. [PDF]
Lee EA +10 more
europepmc +1 more source
Controllable Ion-Repulsion Enables Rapid and Trace-Level Detection of Hydrophobic Sulfonylurea Herbicides with ICPMS/MS without the Organic Mode. [PDF]
Lajin B, Goessler W.
europepmc +1 more source

